Clinical Studies Show Positive Effect of Genomic Testing for Non-Small Cell Lung Cancer Patients
Cancer patients who receive molecular test results before starting first-line treatment for metastatic non-squamous non-small cell lung cancer (NSCLC) live longer, according to a recently published study by researchers at the University of Pennsylvania. JCO Precision Oncology. The study was conducted using the electronic medical records of 326 adults, including newly diagnosed Florida Institute for … Read more